Single-Cell Genome Sequencing (SCGS) Market Trends Estimates High Demand By 2027 | 10x Genomics, BD, BGI, Fluidigm, Novogene and QIAGEN

A new research report titled, "Single-Cell Genome Sequencing (SCGS) Market" has been added to the vast repository The Insight Partners. The intelligence report provides an in-depth analysis of the global market on the basis of the different types of products, technologies, industry verticals, applications, and end-users. The Single-Cell Genome Sequencing (SCGS) Market Report is a valuable source of information for businesses and individuals.

Single-cell genome sequencing includes the isolation of a single cell, to amplify as well as sequence the genes that are present within a single cell. The technique aims to enable a better understanding of complex microbial ecosystems and diseases in multicellular organisms. The use of single-cell genome sequencing is expected to increase significantly since they help in revealing molecular changes that play a vital role in carcinogenesis, interactions with the host immune system, and metastasis.

The single-cell genome sequencing (SCGS) market is anticipated to grow in the forecast, owing to the rising prevalence of chronic disease along with an increase in the number of autoimmune disorders. Also, favorable government policies and funding schemes are expected to offer significant growth opportunities in the market during the forecast period.

Get PDF Sample Copy of this Report @ http://bit.ly/2x35ios

Key Players Influencing the Market:

1. 10x Genomics
2. BD
3. BGI
4. Bio-Rad Laboratories, Inc.
5. Fluidigm
6. Novogene Corporation
7. Oxford Nanopore Technologies
8. QIAGEN
9. Takara Bio Inc.
10. Thermo Fisher Scientific Inc.

Market Segmentation :

The global single-cell genome sequencing (SCGS) market is segmented on the basis of product, technology, workflow, disease indication, application, and end user. Based on product, the market is classified as, instruments and reagents. On the basis of technology, the market is categorized as, multiple displacement amplification (MDA), microarray, polymerase chain reaction (PCR), quantitative pcr (qPCR), and sequencing. The single-cell genome sequencing (SCGS) market based on workflow is categorized as, genomic analysis, sample preparation and single cell isolation. On the basis of disease indication, the market is segmented as, cancer, immunology, microbiology, neurobiology, prenatal diagnosis, and other diseases. The single-cell genome sequencing (SCGS) market is categorized based on application such as, cell differentiation/reprogramming, circulating cells, genomic variation, subpopulation characterization, and other applications. Similarly, on the basis of end user, the market is segmented as, academic & research laboratories, biotechnology & biopharmaceutical companies, clinics, and other end users.

Major Factors :

Global Single-Cell Genome Sequencing (SCGS) Market Overview
Economic Impact on Market
Market Competition
Global Single-Cell Genome Sequencing (SCGS) Market Analysis by Application
Industrial Chain, Sourcing Strategy and Downstream Buyers
Marketing Strategy Analysis, Distributors/Traders
Global Single-Cell Genome Sequencing (SCGS) Market Effect, Factors, Analysis
Global Single-Cell Genome Sequencing (SCGS) Market Forecast

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global single-cell genome sequencing (SCGS) market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The single-cell genome sequencing (SCGS) market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting single-cell genome sequencing (SCGS) market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the single-cell genome sequencing (SCGS) market in these regions.

Request for Buy Report @ http://bit.ly/2TV1Bud

Major highlights of the report :

All-inclusive evaluation of the parent market
Evolution of significant market aspects
Industry-wide investigation of market segments
Assessment of market value and volume in past, present, and forecast years
Evaluation of market share
Study of niche industrial sectors
Tactical approaches of market leaders
Lucrative strategies to help companies strengthen their position in the market

Contact Us:

The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.